These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 7704922)

  • 1. Public health control of hepatitis A: memorandum from a WHO meeting.
    Bull World Health Organ; 1995; 73(1):15-20. PubMed ID: 7704922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of immunization against hepatitis A.
    Lemon SM; Shapiro CN
    Infect Agents Dis; 1994 Feb; 3(1):38-49. PubMed ID: 7952926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hepatitis A virus infection.
    Moyer L; Warwick M; Mahoney FJ
    Am Fam Physician; 1996 Jul; 54(1):107-14. PubMed ID: 8677827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination against hepatitis A].
    Germanaud J; Causse X
    Servir; 1994; 42(3):161-4. PubMed ID: 8059246
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis A: epidemiology and prevention.
    Feinstone SM
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):300-5. PubMed ID: 8781894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the control of viral hepatitis: memorandum from a WHO meeting.
    Bull World Health Organ; 1988; 66(4):443-55. PubMed ID: 2971466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; GarcĂ­a Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
    Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
    [No Abstract]   [Full Text] [Related]  

  • 9. [Who in The Netherlands is eligible for immunization with inactivated hepatitis A vaccine?].
    Leentvaar-Kuijpers A
    Ned Tijdschr Geneeskd; 1994 May; 138(19):941-2. PubMed ID: 8196784
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis A vaccine.
    Bader TF
    Am J Gastroenterol; 1996 Feb; 91(2):217-22. PubMed ID: 8607483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the control of hepatitis A by vaccination.
    Kane MA
    Vaccine; 1992; 10 Suppl 1():S93-6. PubMed ID: 1335670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
    Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of hepatitis A by inactivated vaccines: unanswered questions and unresolved issues.
    Purcell RH
    J Hepatol; 1993; 18 Suppl 2():S61-4. PubMed ID: 8182277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of live attenuated hepatitis A vaccine (H2-strain).
    Mao JS; Chen NL; Huang HY; Chai SA; Dong DX; Cao YY; Zhang HY; Wu DM; Zhang SY
    Chin Med J (Engl); 1992 Mar; 105(3):189-93. PubMed ID: 1327667
    [No Abstract]   [Full Text] [Related]  

  • 16. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology.
    Hendrickx G; Van Herck K; Vorsters A; Wiersma S; Shapiro C; Andrus JK; Ropero AM; Shouval D; Ward W; Van Damme P
    J Viral Hepat; 2008 Oct; 15 Suppl 2():1-15. PubMed ID: 18837827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The future of viral hepatitis vaccines].
    Shdanov VM
    Z Gesamte Hyg; 1985 Mar; 31(3):134-7. PubMed ID: 2990115
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis A vaccination: a sensible luxury?].
    Holzer RB
    Schweiz Rundsch Med Prax; 1993 Feb; 82(7):183-5. PubMed ID: 8382372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The trial preparation of attenuated live hepatitis A vaccine.
    Dong DX; Lian YH; Chen TQ; Li J; Liang WS; Cao YY; Mao JS; Chen NL; Chai SA; Huang HY
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(4):199-202. PubMed ID: 2854634
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis A: from epidemic jaundice to a vaccine-preventable disease.
    Levinthal G; Ray M
    Gastroenterologist; 1996 Jun; 4(2):107-17. PubMed ID: 8792141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.